| P50 | author | Mamunur Rashid | Q86616747 |
| P2093 | author name string | Sandeep K Singh | |
| | Shweta Sharma | |
| | Jiaur R Gayen | |
| | Prabhat R Mishra | |
| | Sudhir Shahi | |
| | Vishal Makadia | |
| | Mohammed Wahajuddin | |
| P2860 | cites work | The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol | Q46482181 |
| | Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo | Q46487609 |
| | Combination of Pluronic/Vitamin E TPGS as a potential inhibitor of drug precipitation | Q46734288 |
| | Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption | Q47288178 |
| | Effect of particle size on the dissolution behaviors of poorly water-soluble drugs | Q47293380 |
| | Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation | Q47968123 |
| | Development and evaluation of emulsion-liposome blends for resveratrol delivery. | Q50717843 |
| | Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma. | Q50983492 |
| | A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer. | Q51732207 |
| | Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability. | Q53111520 |
| | Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells. | Q53614518 |
| | Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation. | Q54447168 |
| | A screening study of surface stabilization during the production of drug nanocrystals | Q59285630 |
| | Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability | Q62721284 |
| | Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation | Q83197756 |
| | Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth | Q83523273 |
| | Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology | Q85240756 |
| | A comparative study on the effects of amphiphilic and hydrophilic polymers on the release profiles of a poorly water-soluble drug | Q86247679 |
| | Crystal structure of quinone reductase 2 in complex with resveratrol | Q28280502 |
| | Cancer chemopreventive activity of resveratrol, a natural product derived from grapes | Q28300555 |
| | Production and characterization of a budesonide nanosuspension for pulmonary administration | Q30825039 |
| | Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection | Q30831971 |
| | Production and characterization of Hesperetin nanosuspensions for dermal delivery | Q33402012 |
| | Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension | Q33777783 |
| | Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics | Q34291656 |
| | Development of curcumin nanocrystal: physical aspects | Q34437322 |
| | Resveratrol, a phenolic antioxidant with effects on blood platelet functions | Q34559219 |
| | Comparision of piceid and resveratrol in antioxidation and antiproliferation activities in vitro. | Q34559483 |
| | Nimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorption | Q34577768 |
| | Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery | Q35122772 |
| | Anti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitro | Q35149578 |
| | Nanosuspensions: a promising drug delivery strategy. | Q35826447 |
| | Cardiovascular protective effects of resveratrol | Q35922166 |
| | Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement | Q36047576 |
| | Comparative studies of the antioxidant effects of cis- and trans-resveratrol | Q36386435 |
| | Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors | Q36386443 |
| | Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals | Q36404933 |
| | Paclitaxel nanocrystals for overcoming multidrug resistance in cancer | Q36623275 |
| | Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives | Q37190153 |
| | Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. | Q37249988 |
| | Resveratrol in cancer management: where are we and where we go from here? | Q37831945 |
| | Administration of resveratrol: What formulation solutions to bioavailability limitations? | Q37943051 |
| | Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery | Q38199319 |
| | A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity. | Q39045085 |
| | Preparation and antitumor study of camptothecin nanocrystals | Q39523351 |
| | Resveratrol cocrystals with enhanced solubility and tabletability. | Q39630720 |
| | Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria | Q40085440 |
| | Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18. | Q43136955 |
| | Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen | Q44061486 |
| | Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers | Q44627074 |
| | Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems | Q45824631 |
| P433 | issue | 3 | |
| P304 | page(s) | 395-407 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | Drug delivery and translational research | Q27723621 |
| P1476 | title | Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration | |
| P478 | volume | 7 | |